Micro Labs Limited Febuxostat Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Febuxostat Export Records India — #15 Exporter, 97 Shipments, $392.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Febuxostat

India Pharmaceutical Trade Intelligence

$48.9M182 Suppliers91 CountriesHS 30049099

ExportsIndia → PHILIPPINES52.3%India → UNITED STATES23.7%

ImportsCHINA → India$10.6K UNITED STATES → India$5.5K

#1 Supplier: AJANTA PHARMA #1 Buyer: UNILAB INC

Micro Labs Limited — Febuxostat Exporter #15 | $392.0K Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Febuxostat Exporter Profile

Indian Pharmaceutical Exporter · #15 for Febuxostat · $392.0K export value · DGFT Verified

Micro Labs Limited is the #15 Indian exporter of Febuxostat with $392.0K in export value and 97 verified shipments. Micro Labs Limited holds a 0.8% market share in Febuxostat exports across 10 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Febuxostat Export Profile: Buyers & Destinations

Micro Labs Limited Febuxostat export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Febuxostat?

Country	Value	Shipments	Share
NIGERIA	$85.1K	6	19.0%
UGANDA	$58.1K	21	13.0%
FRANCE	$53.8K	18	12.0%
PHILIPPINES	$52.7K	3	11.8%
KENYA	$46.7K

Who Are the Top Buyers of Febuxostat from Micro Labs Limited?

Buyer	Country	Value	Orders
MICRO NOVA PHARMACEUTICALS IND	NIGERIA	$85.1K	6
BROWN AND BURK PHILIPPINES INC	PHILIPPINES	$52.7K	3
M/S LABOREX KENYA LIMITED	KENYA	$40.4K	7
E.P.DIS	FRANCE	$33.2K	11
HAWKARY PHARMACEUTICAL COMPANY#	IRAQ	$29.5K	2
MICRO HEALTHCARE PRIVATE LIMITED	SRI LANKA	$26.6K	2
PHILLIPS PHARMACEUTICALS (UGANDA)	UGANDA	$22.8K	6
PHILLIPS PHARMACEUTICALS	ZAMBIA	$21.9K	11
WESSEX PHARMACEUTICALS (RWANDA)	RWANDA	$17.5K	9
PHILLIPS PHARMACEUTICALS(UGANDA)	UGANDA	$16.6K	6

Micro Labs Limited supplies Febuxostat to 30 buyers globally. The largest buyer is MICRO NOVA PHARMACEUTICALS IND (NIGERIA), followed by BROWN AND BURK PHILIPPINES INC (PHILIPPINES) and M/S LABOREX KENYA LIMITED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Febuxostat Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
MEBUX 40 Febuxostat Tablets 40mg 3X10S	$33.6K	2
RUXTA 40 Febuxostat 40mg Tablets 3X10S	$25.4K	1
MEBUX 40 (FEBUXOSTAT TABLETS 40MG)( 3X10`S ) ( QTY- 12687.000 )TAX INV NO: 701209848/24.02.2025	$18.0K	1
RUXTA 80 Febuxostat Tablets 80mg 3X10 s X 6392 Tablets	$14.3K	1
XANURIX 40 FEBUXOSTAT TABLETS 40MG 3X10 S QTY 3360 000 TAX INV NO 701210168 03 05 2025	$14.1K	2
RUXTA 80 Febuxostat Tablets 80mg 3X10S QTY- 6366.000	$13.6K	1
RUXTA 80 (FEBUXOSTAT TABLETS 80MG) 3 X 1	$13.4K	1
XANURIX 40 Febuxostat Tablets 40mg 3X10S QTY- 4320.000	$13.3K	1
XANURIX 40 Batch No: FSAH0016 Febuxostat Tablets 40mg 3X10S QTY- 4320.000	$13.3K	1
MEBUX 40 (FEBUXOSTAT TABLETS 40MG) (3X10s) - TAX INVOICE NO: 701209681 DT: 06.01.2025	$12.8K	1

Micro Labs Limited exports 84 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEBUX 40 Febuxostat Tablets 40mg 3X10S with 2 shipments worth $33.6K.

How Does Micro Labs Limited Compare to Nearest Febuxostat Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	MYLAN LABORATORIES LIMITED	$414.0K	16	5	$25.9K
14	ZYDUS LIFESCIENCES LIMITED	$398.4K	22	5	$18.1K
15	MICRO LABS LIMITED ★	$392.0K	97	10	$4.0K

Micro Labs Limited ranks #15 among 182 Indian Febuxostat exporters. Average shipment value of $4.0K compared to the market average of $132.8K. The closest competitors by value are MYLAN LABORATORIES LIMITED and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Febuxostat Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	639	18.3%
SAHAR AIR	615	17.6%
DELHI AIR	387	11.1%
SAHAR AIR CARGO ACC (INBOM4)	351	10.0%
NHAVA SHEVA SEA (INNSA1)	145	4.1%
HYDERABAD ICD (INSNF6)	98	2.8%
HYDERABAD AIR	96	2.7%
Bombay Air	84	2.4%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Febuxostat Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 100 individual customs records matching Micro Labs Limited exporting Febuxostat, covering 84 formulations to 11 countries via 30 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 91+ countries, 421+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Febuxostat

Febuxostat

Micro Labs Limited — Febuxostat Exporter Profile

Micro Labs Limited — Febuxostat Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Febuxostat?

Who Are the Top Buyers of Febuxostat from Micro Labs Limited?

What Is India's Total Febuxostat Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Febuxostat Exports?

How Does Micro Labs Limited Compare to Other Indian Febuxostat Exporters?

What Febuxostat Formulations Does Micro Labs Limited Export?

Regulatory Requirements: Exporting Febuxostat to Key Markets

Nigeria — NAFDAC

How Does Micro Labs Limited Compare to Nearest Febuxostat Exporters?

Which Indian Ports Ship Febuxostat Exports?

Geopolitical & Trade Policy Impact on Micro Labs Limited's Febuxostat Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Febuxostat Export Data from Micro Labs Limited

Febuxostat Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source